Jci_page_head_homepage_01 Jci_page_head_homepage_02
Masahiro Murakami, Loc T. Nguyen, Zhen W. Zhang, Karen L. Moodie, Peter Carmeliet, Radu V. Stan, Michael Simons
Published in Volume 118, Issue 10
J Clin Invest. 2008; 118(10):3355–3366 doi:10.1172/JCI35298
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 7
Tight junction and venous cells are similarly affected by FGF signaling inhibition.

(A) Immunostaining of quiescent endothelial monolayer (BAECs) transduced with Ad-GFP or Ad-FGFR1DN-GFP. Cells were stained for VE-cadherin (red) and ZO-1 (green). The Ad-FGFR1DN-GFP vector has a bidirectional promoter encoding both GFP and FGFR1DN as described above (GFP signal is shown in white). Arrows indicate reduced VE-cadherin and ZO-1 staining and gaps between endothelial cells. Scale bars: 20 μm. (B) Immunostaining of quiescent venous endothelial monolayer. HSVECs were transduced with Ad-GFP or Ad-FGFR1DN-GFP and stained for VE-cadherin (red) and p120-catenin (green) 24 hours later. Note loss of VE-cadherin and p120-catenin staining at cell-cell contacts and formation of intercellular gaps of FGFR1DN-GFP–transduced cells (white arrows). Scale bars: 20 μm.